Patent Term Extension Application for LEQSELVI™ (deuruxolitinib), Patent No. 10,561,659
🏛 Food and Drug Administration (FDA)FDA-2024-E-5428
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.